Us Food And Drug Administration
same was mentioned for last week . However, We feel that pharmaceutical shares may see some more gains as investors will once again look for bargain buys in the sector on positive news. Shares of Cadila Healthcare continued to rise and ended up 4.8% after it got approval from the US Food and Drug
12.44 PM Feb 19th
, and Waluj and Chikalthana in Maharashtra, which are under US Food and Drug Administration`s import alert. Timelines on the resolution of the regulatory issues would be a key issue to watch out for in the earnings. For time being avoid longs in Pharma stocks or consider as long term investment
5.21 PM Jan 21st
in a sustainable manner in mid to long term. The Capital-based firm has received approval from the US Food and Drug Administration (USFDA) to market its generic product to treat migraine in strenghts of 5 and 10 mg, Panacea Biotec said in a statement. Panacea`s product is equivalent to Merck & Co`s Maxalt
12.27 PM Jan 19th
Source:----BL:----) January 18, 2017: Panacea Biotec on Wednesday said the US Food and Drug Administration has approved the company s abbreviated new drug application for rizatritan benzoate orally disintegrating tablets of 5 mg and 10 mg strengths, which is the generic equivalent of Maxalt
9.26 PM Jan 18th
Following the approval from the US Food and Drug Administration for its generic version of Bendamustine Hydrochloride powder for injection, 25 mg/vial and 100 mg/vial (singe-dose vial), Natco Pharma will launch the drug on November 1, 2019 or earlier in the US market.
4.38 PM Jan 10th
will continue to supply of APIs across European Union that contributed about 37 percent of company`s revenue in FY16. Three days back, the same active pharmaceutical ingredient plant had received a warning letter from the US Food and Drug Administration. The USFDA had imposed import alert on the company
2.03 PM Jan 9th
Natco Pharma Ltd today said following the approval from US Food and Drug Administration for its generic version of Bendamustine Hydrochloride powder for injection, 25 mg/Vial and 100 mg/Vial (Singe-Dose Vial), it will launch the drug on November 1, 2019 or earlier in USA market.
2.22 PM Jan 6th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.